Literature DB >> 35869389

Implantable vision-enhancing devices and postoperative rehabilitation in advanced age-related macular degeneration.

Andreas F Borkenstein1, Eva-Maria Borkenstein2, Albert J Augustin3.   

Abstract

Age-related macular degeneration (AMD) results in progressive vision loss that significantly impacts patients' quality of life and ability to perform routine daily activities. Although pharmaceutical treatments for AMD are available and in clinical development, patients with late-stage AMD are relatively underserved. Specialized rehabilitation programs and external low-vision aids are available to support visual performance for those with advanced AMD; but intraocular vision-improving devices, including implantable miniature telescope (IMT) and intraocular lens (IOL) implants, offer advantages regarding head motion, vestibular ocular reflex development, and depth perception. IMT and IOL technologies are rapidly evolving, and many patients who could benefit from them remain unidentified. This review of recent literature summarizes available information on implantable devices for improving vision in patients with advanced AMD. Furthermore, it discusses recent attempts of developing the quality of life tests including activities of daily life and objective assessments. This may offer the ophthalmologist but also the patient a better possibility to detect changes or improvements before and after surgery. It is evident that surgery with new implants/devices is no longer the challenge, but rather the more complex management of patients before and after surgery as well as the correct selection of cases.
© 2022. The Author(s).

Entities:  

Year:  2022        PMID: 35869389     DOI: 10.1038/s41433-022-02179-z

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  39 in total

1.  Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.

Authors:  Norman Waugh; Emma Loveman; Jill Colquitt; Pamela Royle; Jian Lee Yeong; Geraldine Hoad; Noemi Lois
Journal:  Health Technol Assess       Date:  2018-05       Impact factor: 4.014

Review 2.  AGE-RELATED MACULAR DEGENERATION.

Authors:  Andreea Gheorghe; Labib Mahdi; Ovidiu Musat
Journal:  Rom J Ophthalmol       Date:  2015 Apr-Jun

Review 3.  Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review.

Authors:  Neil M Schultz; Shweta Bhardwaj; Claudia Barclay; Luis Gaspar; Jason Schwartz
Journal:  Clin Ther       Date:  2021-09-20       Impact factor: 3.393

Review 4.  Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis.

Authors:  Wan Ling Wong; Xinyi Su; Xiang Li; Chui Ming G Cheung; Ronald Klein; Ching-Yu Cheng; Tien Yin Wong
Journal:  Lancet Glob Health       Date:  2014-01-03       Impact factor: 26.763

Review 5.  Neovascular Age-Related Macular Degeneration.

Authors:  Jack Shao; Maria M Choudhary; Andrew P Schachat
Journal:  Dev Ophthalmol       Date:  2015-10-26

6.  Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.

Authors:  David S Liao; Federico V Grossi; Delphine El Mehdi; Monica R Gerber; David M Brown; Jeffrey S Heier; Charles C Wykoff; Lawrence J Singerman; Prema Abraham; Felix Grassmann; Peter Nuernberg; Bernhard H F Weber; Pascal Deschatelets; Robert Y Kim; Carol Y Chung; Ramiro M Ribeiro; Mohamed Hamdani; Philip J Rosenfeld; David S Boyer; Jason S Slakter; Cedric G Francois
Journal:  Ophthalmology       Date:  2019-07-16       Impact factor: 14.277

Review 7.  Reading aids for adults with low vision.

Authors:  Gianni Virgili; Ruthy Acosta; Sharon A Bentley; Giovanni Giacomelli; Claire Allcock; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2018-04-17

Review 8.  Current Approaches to Low Vision (Re)Habilitation

Authors:  Deniz Altınbay; Şefay Aysun İdil
Journal:  Turk J Ophthalmol       Date:  2019-06-27

Review 9.  Intraocular vision-improving devices in age-related macular degeneration.

Authors:  Andrzej Grzybowski; Jin Wang; Feifei Mao; Dabo Wang; Ningli Wang
Journal:  Ann Transl Med       Date:  2020-11

10.  C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial.

Authors:  Glenn J Jaffe; Keith Westby; Karl G Csaky; Jordi Monés; Joel A Pearlman; Sunil S Patel; Brian C Joondeph; John Randolph; Harvey Masonson; Kourous A Rezaei
Journal:  Ophthalmology       Date:  2020-09-01       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.